Eastern Cape Province Has High Levels Of Resistance To Injectable Second-Line Drugs In Patients Starting Treatment For MDR-TB

被引：0
|
作者：
Kvasnovsky, C.
Odendaal, R.
Brand, J.
Lancaster, J.
Dalton, T.
Wolfgang, M.
van der Walt, M.
Ershova, J.
Cegielski, J. P.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4034
引用
收藏
页数：1
相关论文
共 23 条
  • [21] Frequency of Herero-Resistance to First- and Second-Line Anti-Tuberculosis (TB) Drugs in a Population-Based Sample of Drug-Resistant TB Patients
    Berger, C. A.
    Allender, C.
    Hunat, M.
    Sedusta, A.
    Sacopon, C.
    Sabalboro, J.
    Bascuna, J.
    Schwem, B.
    Dela Tonga, A.
    Ama, M.
    Destura, R.
    Cattamanchi, A.
    Kato-Maeda, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [22] Nivolumab as second-line treatment of patients with metastatic renal cell carcinoma with high or normal fibrinogen levels: A prospective, cohort study
    Tsimafeyeu, Ilya
    Volkova, Maria
    Utyashev, Igor A.
    Gerk, Ivan
    Zakurdaeva, Kristina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] PREVALENCE AND RISK FACTORS FOR EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS AND OTHER SECOND LINE DRUG RESISTANCE AMONG PATIENTS STARTING TREATMENT FOR MULTIDRUG RESISTANT TB IN THE COUNTRY OF GEORGIA
    Gegia, M.
    Kourbatova, E. V.
    Leonard, M. K.
    Kalandadze, I.
    Blumberg, H. M.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 486 - 487
123